右美托咪定通过HIF-1α对缺血性脑卒中线粒体功能的调控
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金委员会资助项目(81960053);新疆维吾尔自治区自然科学基金资助项目(2020D01C236)


Regulation of dexmedetomidine on mitochondrial function in ischemia stroke through HIF-1α
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 基于HIF-1α对线粒体功能调节作用,探讨右美托咪定对缺血性脑卒中大鼠神经功能的保护。方法 将48只SD大鼠随机分为假手术组、脑缺血组和右美托咪定组、右美托咪定+YC-1组。除假手术组大鼠,各组大鼠采用Longa法构建脑缺血再灌注模型,期间腹腔注射右美托咪定(50 μg/kg)或YC-1(5 mg/kg)。24 h后先评估大鼠神经功能与脑梗死体积占比,再取脑组织后提取线粒体检测线粒体膜电位与线粒体呼吸链复合物活性,最后通过试剂盒检测ROS、GSH与ATP水平,以Western blot检测HIF-1α表达。结果 脑缺血组大鼠神经功能评分降低,出现了脑梗死区域。与脑缺血组相比,右美托咪定明显增加了大鼠的神经功能评分,减少了脑梗死体积占比。此外,右美托咪定上调了线粒体膜电位水平,提高了线粒体呼吸链复合物Ⅰ/Ⅱ/Ⅲ活性。与此同时,右美托咪定组大鼠脑组织中HIF-1α表达明显上调,ROS水平下降的同时GSH与ATP水平明显增加。然而,右美托咪定+YC-1组大鼠脑组织中HIF-1α表达明显降低,且线粒体膜电位明显减低,呼吸链复合物活性降低。最终大鼠神经功能评分增加,脑梗死体积占比增加。结论 右美托咪定通过上调HIF-1α表达,改善了线粒体功能,从而降低氧化应激反应,减少脑梗死区域,最终发挥神经功能保护作用。

    Abstract:

    Objective Based on the regulation of mitochondrial function through HIF-1α, to explore the effects of dexmedetomidine on the neurological function of rats with ischemic stroke. Methods 48 SD rats were randomly divided into Sham group, Ischemia stroke group, Dexmedetomidine group, and Dexmedetomidine+YC-1 group. Longa method was applied to construct cerebral ischemia / reperfusion model in rats except for Sham group, during which dexmedetomidine (50 μg/kg) or YC-1 (5mg/kg) was injected intraperitoneally. After 24 hours, neurological function and the cerebral infarction volume were evaluated, and then the brains were taken and mitochondria were extracted to detect the activity of mitochondrial membrane potential and mitochondrial respiratory chain complexes. Finally, the levels of ROS, GSH and ATP were detected by the kit, and HIF-1α was detected by Western blot. Results Rats in Ischemia stroke group appeared decreases in the neurological score and cerebral infarction. Compared with Ischemia group, dexmedetomidine significantly increased the neurological scores of rats and reduced the proportion of cerebral infarction volume. In addition, dexmedetomidine up-regulated the level of mitochondrial membrane potential and increased the activity of mitochondrial respiratory chain complex Ⅰ/Ⅱ/Ⅲ. At the same time, the expression of HIF-1α in brain of the dexmedetomidine group was significantly increased, and the level of ROS decreased while the level of GSH and ATP increased significantly. However, the expression of HIF-1α in the brain tissue of rats in the dexmedetomidine+YC-1 group significantly reduced, and the mitochondrial membrane potential significantly reduced, the activity of respiratory chain complexes reduced as well. In the end, rats showed an increase in neurological score and an increase in the proportion of cerebral infarction volume. Conclusion Dexmedetomidine improves mitochondrial function by up-regulating the expression of HIF-1α, thereby reducing oxidative stress, reducing cerebral infarction areas, and ultimately exerting neuroprotective effects.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司